{ "x402Version": 2, "id": 39574, "slug": "39574", "resource": "https://api.magentlab.com/api/calc/aih_original", "description": "Alvarez 1999 revised original IAIHG AIH score, not Hennes 2008 simplified. Caller-assigned sex, ALP:AST/ALT ratio, globulin/IgG, ANA/SMA/LKM titer, AMA, viral markers, drugs, alcohol, additive histology, other autoimmune disease; optional HLA/other autoantibodies if seronegative and treatment response. Pretreatment definite >15 / probable 10-15; posttreatment definite >17 / probable 12-17. magent does not read histology. Not a diagnosis or immunosuppression order.", "type": "http", "serviceName": "magent", "resourceType": "Agent Service", "accepts": [ { "scheme": "exact", "network": "eip155:8453", "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2", "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913", "amount": "5000", "amountUsd": 0.005, "maxTimeoutSeconds": 600 } ], "outputSchema": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" }, "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "alcohol_intake": "gt_60", "alp_ratio": "gt_3", "ama_positive": true, "autoantibody_titer": "lt_1_40", "biliary_changes": true, "globulin_igg": "lt_1x", "hepatotoxic_drugs": true, "hla_dr3_or_dr4": false, "interface_hepatitis": false, "liver_cell_rosettes": false, "lymphoplasmacytic_infiltrate": false, "other_atypical_histology": true, "other_autoantibodies": false, "other_autoimmune_disease": false, "sex": "male", "treatment_response": "none", "viral_markers_positive": true }, { "alcohol_intake": "gt_60", "alp_ratio": "gt_3", "ama_positive": true, "autoantibody_titer": "lt_1_40", "biliary_changes": true, "globulin_igg": "lt_1x", "hepatotoxic_drugs": true, "hla_dr3_or_dr4": false, "interface_hepatitis": false, "liver_cell_rosettes": false, "lymphoplasmacytic_infiltrate": false, "other_atypical_histology": true, "other_autoantibodies": false, "other_autoimmune_disease": false, "sex": "male", "treatment_response": "none", "viral_markers_positive": true } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "aih_band": "not_aih", "citation": { "authors": "Alvarez F, Berg PA, Bianchi FB, et al.", "doi": "10.1016/s0168-8278(99)80297-9", "id": "alvarez-1999", "pmid": "10580593", "source": "J Hepatol. 1999;31(5):929-938", "title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" }, "components": [ { "factor": "sex", "points": 0, "present": false, "value": "male" }, { "factor": "alp_ratio", "points": -2, "present": true, "value": "gt_3" }, { "factor": "globulin_igg", "points": 0, "present": false, "value": "lt_1x" }, { "factor": "autoantibody_titer", "points": 0, "present": false, "value": "lt_1_40" }, { "factor": "ama_positive", "points": -4, "present": true }, { "factor": "viral_markers_positive", "points": -3, "present": true, "value": true }, { "factor": "hepatotoxic_drugs", "points": -4, "present": true, "value": true }, { "factor": "alcohol_intake", "points": -2, "present": true, "value": "gt_60" }, { "factor": "interface_hepatitis", "points": 0, "present": false }, { "factor": "lymphoplasmacytic_infiltrate", "points": 0, "present": false }, { "factor": "liver_cell_rosettes", "points": 0, "present": false }, { "factor": "typical_histology_absent", "points": -5, "present": true }, { "factor": "biliary_changes", "points": -3, "present": true }, { "factor": "other_atypical_histology", "points": -3, "present": true }, { "factor": "other_autoimmune_disease", "points": 0, "present": false }, { "factor": "other_autoantibodies", "points": 0, "present": false }, { "factor": "hla_dr3_or_dr4", "points": 0, "present": false }, { "factor": "treatment_response", "points": 0, "present": false, "value": "none" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "aih_original", "formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17", "max_score": 26, "score": -26, "timing": "pretreatment" }, { "aih_band": "not_aih", "citation": { "authors": "Alvarez F, Berg PA, Bianchi FB, et al.", "doi": "10.1016/s0168-8278(99)80297-9", "id": "alvarez-1999", "pmid": "10580593", "source": "J Hepatol. 1999;31(5):929-938", "title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" }, "components": [ { "factor": "sex", "points": 0, "present": false, "value": "male" }, { "factor": "alp_ratio", "points": -2, "present": true, "value": "gt_3" }, { "factor": "globulin_igg", "points": 0, "present": false, "value": "lt_1x" }, { "factor": "autoantibody_titer", "points": 0, "present": false, "value": "lt_1_40" }, { "factor": "ama_positive", "points": -4, "present": true }, { "factor": "viral_markers_positive", "points": -3, "present": true, "value": true }, { "factor": "hepatotoxic_drugs", "points": -4, "present": true, "value": true }, { "factor": "alcohol_intake", "points": -2, "present": true, "value": "gt_60" }, { "factor": "interface_hepatitis", "points": 0, "present": false }, { "factor": "lymphoplasmacytic_infiltrate", "points": 0, "present": false }, { "factor": "liver_cell_rosettes", "points": 0, "present": false }, { "factor": "typical_histology_absent", "points": -5, "present": true }, { "factor": "biliary_changes", "points": -3, "present": true }, { "factor": "other_atypical_histology", "points": -3, "present": true }, { "factor": "other_autoimmune_disease", "points": 0, "present": false }, { "factor": "other_autoantibodies", "points": 0, "present": false }, { "factor": "hla_dr3_or_dr4", "points": 0, "present": false }, { "factor": "treatment_response", "points": 0, "present": false, "value": "none" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "aih_original", "formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17", "max_score": 26, "score": -26, "timing": "pretreatment" } ], "path": "/api/calc/aih_original" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "alcohol_intake": { "description": "Caller-assigned average alcohol intake (Alvarez 1999). lt_25 (<25 g/day) scores 2; 25_to_60 scores 0 (gap between the tabulated <25 and >60 cells); gt_60 (>60 g/day) scores -2.", "enum": [ "lt_25", "25_to_60", "gt_60" ], "type": "string" }, "alp_ratio": { "description": "Caller-assigned ALP:(AST or ALT) ratio as multiples of ULN (Alvarez 1999 note 1). lt_1_5 (<1.5) scores 2; 1_5_to_3 (1.5–3.0) scores 0; gt_3 (>3) scores -2. magent does not take raw enzymes.", "enum": [ "lt_1_5", "1_5_to_3", "gt_3" ], "type": "string" }, "ama_positive": { "description": "Caller-assigned antimitochondrial antibody. true scores -4; false scores 0 (Alvarez 1999). magent does not assay AMA.", "type": "boolean" }, "autoantibody_titer": { "description": "Caller-assigned highest ANA, SMA, or LKM-1 immunofluorescence titer (Alvarez 1999). lt_1_40 scores 0; 1_40 scores 1; 1_80 scores 2; gt_1_80 scores 3. magent does not titer autoantibodies.", "enum": [ "lt_1_40", "1_40", "1_80", "gt_1_80" ], "type": "string" }, "biliary_changes": { "description": "Caller-assigned biliary changes typical of PBC or PSC (Alvarez 1999 note 5). true scores -3; additive with other histology items. magent does not read histology.", "type": "boolean" }, "globulin_igg": { "description": "Caller-assigned serum globulin or IgG as multiples of ULN (Alvarez 1999). lt_1x scores 0; 1_to_1_5x scores 1; 1_5_to_2x scores 2; gt_2x scores 3. magent does not assay globulin or IgG.", "enum": [ "lt_1x", "1_to_1_5x", "1_5_to_2x", "gt_2x" ], "type": "string" }, "hepatotoxic_drugs": { "description": "Recent or current known or suspected hepatotoxic drugs (Alvarez 1999 note 4). true scores -4; false scores 1.", "type": "boolean" }, "hla_dr3_or_dr4": { "description": "Optional. HLA DR3 or DR4 (Alvarez 1999 note 9). true scores 1 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0.", "type": "boolean" }, "interface_hepatitis": { "description": "Caller-assigned interface hepatitis on liver histology. true scores 3 (Alvarez 1999; additive). magent does not read histology.", "type": "boolean" }, "liver_cell_rosettes": { "description": "Caller-assigned liver-cell rosettes. true scores 1 (Alvarez 1999; additive). magent does not read histology.", "type": "boolean" }, "lymphoplasmacytic_infiltrate": { "description": "Caller-assigned predominantly lymphoplasmacytic infiltrate. true scores 1 (Alvarez 1999; additive). magent does not read histology.", "type": "boolean" }, "other_atypical_histology": { "description": "Caller-assigned other prominent histologic features suggesting a different etiology (Alvarez 1999 note 6). true scores -3; additive. magent does not read histology.", "type": "boolean" }, "other_autoantibodies": { "description": "Optional. Seropositivity for other defined autoantibodies (pANCA, anti-LC1, anti-SLA, anti-ASGPR, anti-LP, anti-sulfatide; Alvarez 1999 note 8). true scores 2 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0.", "type": "boolean" }, "other_autoimmune_disease": { "description": "Any other autoimmune disorder in the patient or first-degree relatives (Alvarez 1999 note 7). true scores 2; false scores 0.", "type": "boolean" }, "sex": { "description": "Caller-assigned sex (Alvarez 1999). female scores 2; male scores 0. magent does not examine the patient.", "enum": [ "female", "male" ], "type": "string" }, "treatment_response": { "description": "Optional. Alvarez 1999 response to therapy, added to presentation points. none or omit: pretreatment bands (definite >15, probable 10-15). complete scores 2; relapse scores 3; both use posttreatment bands (definite >17, probable 12-17). Not an immunosuppression order.", "enum": [ "none", "complete", "relapse" ], "type": "string" }, "viral_markers_positive": { "description": "Caller-assigned hepatitis A/B/C viral markers (Alvarez 1999 note 3). true scores -3; false (negative) scores 3. magent does not interpret viral serology.", "type": "boolean" } }, "required": [ "sex", "alp_ratio", "globulin_igg", "autoantibody_titer", "ama_positive", "viral_markers_positive", "hepatotoxic_drugs", "alcohol_intake", "interface_hepatitis", "lymphoplasmacytic_infiltrate", "liver_cell_rosettes", "biliary_changes", "other_atypical_histology", "other_autoimmune_disease" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } }, "tags": [ "aih-original", "autoimmune", "hepatitis", "liver", "calculator", "bazaar" ], "sourceHost": "api.magentlab.com", "lastUpdated": "2026-10-12T13:51:58.371Z", "quality": { "calls30d": 3, "uniquePayers30d": 1, "lastCalledAt": "2026-10-12T13:51:58.226Z" }, "metadata": { "serviceName": "magent", "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "alcohol_intake": "gt_60", "alp_ratio": "gt_3", "ama_positive": true, "autoantibody_titer": "lt_1_40", "biliary_changes": true, "globulin_igg": "lt_1x", "hepatotoxic_drugs": true, "hla_dr3_or_dr4": false, "interface_hepatitis": false, "liver_cell_rosettes": false, "lymphoplasmacytic_infiltrate": false, "other_atypical_histology": true, "other_autoantibodies": false, "other_autoimmune_disease": false, "sex": "male", "treatment_response": "none", "viral_markers_positive": true }, { "alcohol_intake": "gt_60", "alp_ratio": "gt_3", "ama_positive": true, "autoantibody_titer": "lt_1_40", "biliary_changes": true, "globulin_igg": "lt_1x", "hepatotoxic_drugs": true, "hla_dr3_or_dr4": false, "interface_hepatitis": false, "liver_cell_rosettes": false, "lymphoplasmacytic_infiltrate": false, "other_atypical_histology": true, "other_autoantibodies": false, "other_autoimmune_disease": false, "sex": "male", "treatment_response": "none", "viral_markers_positive": true } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "aih_band": "not_aih", "citation": { "authors": "Alvarez F, Berg PA, Bianchi FB, et al.", "doi": "10.1016/s0168-8278(99)80297-9", "id": "alvarez-1999", "pmid": "10580593", "source": "J Hepatol. 1999;31(5):929-938", "title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" }, "components": [ { "factor": "sex", "points": 0, "present": false, "value": "male" }, { "factor": "alp_ratio", "points": -2, "present": true, "value": "gt_3" }, { "factor": "globulin_igg", "points": 0, "present": false, "value": "lt_1x" }, { "factor": "autoantibody_titer", "points": 0, "present": false, "value": "lt_1_40" }, { "factor": "ama_positive", "points": -4, "present": true }, { "factor": "viral_markers_positive", "points": -3, "present": true, "value": true }, { "factor": "hepatotoxic_drugs", "points": -4, "present": true, "value": true }, { "factor": "alcohol_intake", "points": -2, "present": true, "value": "gt_60" }, { "factor": "interface_hepatitis", "points": 0, "present": false }, { "factor": "lymphoplasmacytic_infiltrate", "points": 0, "present": false }, { "factor": "liver_cell_rosettes", "points": 0, "present": false }, { "factor": "typical_histology_absent", "points": -5, "present": true }, { "factor": "biliary_changes", "points": -3, "present": true }, { "factor": "other_atypical_histology", "points": -3, "present": true }, { "factor": "other_autoimmune_disease", "points": 0, "present": false }, { "factor": "other_autoantibodies", "points": 0, "present": false }, { "factor": "hla_dr3_or_dr4", "points": 0, "present": false }, { "factor": "treatment_response", "points": 0, "present": false, "value": "none" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "aih_original", "formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17", "max_score": 26, "score": -26, "timing": "pretreatment" }, { "aih_band": "not_aih", "citation": { "authors": "Alvarez F, Berg PA, Bianchi FB, et al.", "doi": "10.1016/s0168-8278(99)80297-9", "id": "alvarez-1999", "pmid": "10580593", "source": "J Hepatol. 1999;31(5):929-938", "title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" }, "components": [ { "factor": "sex", "points": 0, "present": false, "value": "male" }, { "factor": "alp_ratio", "points": -2, "present": true, "value": "gt_3" }, { "factor": "globulin_igg", "points": 0, "present": false, "value": "lt_1x" }, { "factor": "autoantibody_titer", "points": 0, "present": false, "value": "lt_1_40" }, { "factor": "ama_positive", "points": -4, "present": true }, { "factor": "viral_markers_positive", "points": -3, "present": true, "value": true }, { "factor": "hepatotoxic_drugs", "points": -4, "present": true, "value": true }, { "factor": "alcohol_intake", "points": -2, "present": true, "value": "gt_60" }, { "factor": "interface_hepatitis", "points": 0, "present": false }, { "factor": "lymphoplasmacytic_infiltrate", "points": 0, "present": false }, { "factor": "liver_cell_rosettes", "points": 0, "present": false }, { "factor": "typical_histology_absent", "points": -5, "present": true }, { "factor": "biliary_changes", "points": -3, "present": true }, { "factor": "other_atypical_histology", "points": -3, "present": true }, { "factor": "other_autoimmune_disease", "points": 0, "present": false }, { "factor": "other_autoantibodies", "points": 0, "present": false }, { "factor": "hla_dr3_or_dr4", "points": 0, "present": false }, { "factor": "treatment_response", "points": 0, "present": false, "value": "none" } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "aih_original", "formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17", "max_score": 26, "score": -26, "timing": "pretreatment" } ], "path": "/api/calc/aih_original" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "alcohol_intake": { "description": "Caller-assigned average alcohol intake (Alvarez 1999). lt_25 (<25 g/day) scores 2; 25_to_60 scores 0 (gap between the tabulated <25 and >60 cells); gt_60 (>60 g/day) scores -2.", "enum": [ "lt_25", "25_to_60", "gt_60" ], "type": "string" }, "alp_ratio": { "description": "Caller-assigned ALP:(AST or ALT) ratio as multiples of ULN (Alvarez 1999 note 1). lt_1_5 (<1.5) scores 2; 1_5_to_3 (1.5–3.0) scores 0; gt_3 (>3) scores -2. magent does not take raw enzymes.", "enum": [ "lt_1_5", "1_5_to_3", "gt_3" ], "type": "string" }, "ama_positive": { "description": "Caller-assigned antimitochondrial antibody. true scores -4; false scores 0 (Alvarez 1999). magent does not assay AMA.", "type": "boolean" }, "autoantibody_titer": { "description": "Caller-assigned highest ANA, SMA, or LKM-1 immunofluorescence titer (Alvarez 1999). lt_1_40 scores 0; 1_40 scores 1; 1_80 scores 2; gt_1_80 scores 3. magent does not titer autoantibodies.", "enum": [ "lt_1_40", "1_40", "1_80", "gt_1_80" ], "type": "string" }, "biliary_changes": { "description": "Caller-assigned biliary changes typical of PBC or PSC (Alvarez 1999 note 5). true scores -3; additive with other histology items. magent does not read histology.", "type": "boolean" }, "globulin_igg": { "description": "Caller-assigned serum globulin or IgG as multiples of ULN (Alvarez 1999). lt_1x scores 0; 1_to_1_5x scores 1; 1_5_to_2x scores 2; gt_2x scores 3. magent does not assay globulin or IgG.", "enum": [ "lt_1x", "1_to_1_5x", "1_5_to_2x", "gt_2x" ], "type": "string" }, "hepatotoxic_drugs": { "description": "Recent or current known or suspected hepatotoxic drugs (Alvarez 1999 note 4). true scores -4; false scores 1.", "type": "boolean" }, "hla_dr3_or_dr4": { "description": "Optional. HLA DR3 or DR4 (Alvarez 1999 note 9). true scores 1 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0.", "type": "boolean" }, "interface_hepatitis": { "description": "Caller-assigned interface hepatitis on liver histology. true scores 3 (Alvarez 1999; additive). magent does not read histology.", "type": "boolean" }, "liver_cell_rosettes": { "description": "Caller-assigned liver-cell rosettes. true scores 1 (Alvarez 1999; additive). magent does not read histology.", "type": "boolean" }, "lymphoplasmacytic_infiltrate": { "description": "Caller-assigned predominantly lymphoplasmacytic infiltrate. true scores 1 (Alvarez 1999; additive). magent does not read histology.", "type": "boolean" }, "other_atypical_histology": { "description": "Caller-assigned other prominent histologic features suggesting a different etiology (Alvarez 1999 note 6). true scores -3; additive. magent does not read histology.", "type": "boolean" }, "other_autoantibodies": { "description": "Optional. Seropositivity for other defined autoantibodies (pANCA, anti-LC1, anti-SLA, anti-ASGPR, anti-LP, anti-sulfatide; Alvarez 1999 note 8). true scores 2 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0.", "type": "boolean" }, "other_autoimmune_disease": { "description": "Any other autoimmune disorder in the patient or first-degree relatives (Alvarez 1999 note 7). true scores 2; false scores 0.", "type": "boolean" }, "sex": { "description": "Caller-assigned sex (Alvarez 1999). female scores 2; male scores 0. magent does not examine the patient.", "enum": [ "female", "male" ], "type": "string" }, "treatment_response": { "description": "Optional. Alvarez 1999 response to therapy, added to presentation points. none or omit: pretreatment bands (definite >15, probable 10-15). complete scores 2; relapse scores 3; both use posttreatment bands (definite >17, probable 12-17). Not an immunosuppression order.", "enum": [ "none", "complete", "relapse" ], "type": "string" }, "viral_markers_positive": { "description": "Caller-assigned hepatitis A/B/C viral markers (Alvarez 1999 note 3). true scores -3; false (negative) scores 3. magent does not interpret viral serology.", "type": "boolean" } }, "required": [ "sex", "alp_ratio", "globulin_igg", "autoantibody_titer", "ama_positive", "viral_markers_positive", "hepatotoxic_drugs", "alcohol_intake", "interface_hepatitis", "lymphoplasmacytic_infiltrate", "liver_cell_rosettes", "biliary_changes", "other_atypical_histology", "other_autoimmune_disease" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } } }, "liveness": { "reliability": null }, "verified": false, "featured": false, "provider": { "host": "api.magentlab.com", "manifest_name": "api.magentlab.com", "source": "cdp-mirror", "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources", "submitted_at": "2026-10-14T01:15:01.050Z" }, "exampleResponse": { "example": {}, "type": "string" } }